Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Casey DA et al. – Irinotecan and temozolomide is a well–tolerated and active regimen for recurrent/progressive ES. Prospective trials are necessary to define the role of this regimen in newly diagnosed ES.

Related Articles

Primary Ewing's sarcoma of the frontal bone with intracranial extension
Journal of Cancer Research and Therapeutics, 10/27/09    Relevance Score: 69%

Isolated CNS vasculitis: Unusual presentation of relapsed Ewing sarcoma
Pediatric Blood & Cancer, 11/12/09    Relevance Score: 68%

Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1
Medical Oncology, 11/04/09    Relevance Score: 66%

Histological heterogeneity of Ewings sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support
Virchows Archiv, 10/27/09    Relevance Score: 66%

Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel
Journal of Pediatric Hematology/Oncology, 11/06/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address